Follow
Zahraa Abdul Sater
Zahraa Abdul Sater
NIH/NIDDK
Verified email at nih.gov
Title
Cited by
Cited by
Year
Chronic mirabegron treatment increases human brown fat, HDL cholesterol, and insulin sensitivity
AE O’Mara, JW Johnson, JD Linderman, RJ Brychta, S McGehee, ...
The Journal of clinical investigation 130 (5), 2209-2219, 2020
2782020
Opportunities and challenges in the therapeutic activation of human energy expenditure and thermogenesis to manage obesity
KY Chen, RJ Brychta, ZA Sater, TM Cassimatis, C Cero, LA Fletcher, ...
Journal of biological chemistry 295 (7), 1926-1942, 2020
1062020
Do patients with familial nonmedullary thyroid cancer present with more aggressive disease? Implications for initial surgical treatment
M El Lakis, A Giannakou, PJ Nockel, D Wiseman, SK Gara, D Patel, ...
Surgery 165 (1), 50-57, 2019
252019
Pheochromocytoma and paraganglioma patients with poor survival often show brown adipose tissue activation
Z Abdul Sater, A Jha, A Hamimi, A Mandl, IR Hartley, S Gubbi, M Patel, ...
The Journal of Clinical Endocrinology & Metabolism 105 (4), 1176-1185, 2020
222020
Proton MR spectroscopy measurements of white and brown adipose tissue in healthy humans: relaxation parameters and unsaturated fatty acids
R Ouwerkerk, A Hamimi, J Matta, KZ Abd-Elmoniem, JF Eary, ...
Radiology 299 (2), 396-406, 2021
192021
Thyroid hormone effects on glucose disposal in patients with insulin receptor mutations
YS Kushchayeva, M Startzell, E Cochran, S Auh, H Sekizkardes, ...
The Journal of Clinical Endocrinology & Metabolism 105 (3), e158-e171, 2020
122020
Diverticular perforation: a fatal complication to forestall in Cushing syndrome
ZA Sater, S Jha, R McGlotten, I Hartley, M El Lakis, KA Araque, ...
The Journal of Clinical Endocrinology & Metabolism 103 (8), 2811-2814, 2018
122018
Combining a β3 adrenergic receptor agonist with alpha‐lipoic acid reduces inflammation in male mice with diet‐induced obesity
Z Abdul Sater, C Cero, AE Pierce, HJ Lea, H Abdul Sater, KY Zhu, N Liu, ...
Obesity 30 (1), 153-164, 2022
92022
Gallbladder Paraganglioma Associated with SDHD Mutation: a Potential Pitfall on 18F-FDOPA PET Imaging
Z Abdul Sater, A Jha, A Mandl, SK Mangelen, JA Carrasquillo, A Ling, ...
Nuclear medicine and molecular imaging 53, 144-147, 2019
92019
IS DABIGATRAN SAFE IN ‘REAL LIFE’?
V Parikh, V Chainani, M Howard, S Doshi, HA Sater, ZA Sater, M Krishnan, ...
Journal of the American College of Cardiology 59 (13S), E602-E602, 2012
32012
FRI466 Toxic Retrosternal Goiter Following SARS-CoV-2 Vaccination
J Schipper, Z Abdul Sater
Journal of the Endocrine Society 7 (Supplement_1), bvad114. 1813, 2023
2023
1177-P: The Reduction in Hepatic Steatosis after Cushing’s Syndrome Treatment Is a Marker of Improving Glycemia
A Pierce, ZA Sater, AM Cypess
Diabetes 70 (Supplement_1), 2021
2021
The Improvement in Hepatic Steatosis After Cushing’s Syndrome Treatment Is an Early Sign of Metabolic Recovery
A Hamimi, ZA Sater, R McGlotten, J Matta, A Pierce, K Abd-elmoniem, ...
Journal of the Endocrine Society 5 (Supplement_1), A98-A98, 2021
2021
1680-P: A Novel Immunomodulatory Combination That Decreases Adipose Tissue and Systemic Inflammation and Improves Metabolism in Dio Mice
ZA Sater, C Cero, HJ Lea, KY Zhu, O Gavrilova, AM Cypess
Diabetes 69 (Supplement_1), 2020
2020
Clinicopathological, Molecular and Genetic Characteristics of Thymic Tumors in Multiple Endocrine Neoplasia 1 Syndrome
A Mandl, J Welch, J Del Rivero, C Cochran, R Merke, D Schrump, ...
PANCREAS 49 (3), 478-479, 2020
2020
SUN-553 Atypical Spindle Cells on a Thyroid Aspirate: A Rare Case of a Thyroid Schwannoma Presenting as a Progressively Expanding Thyroid Nodule
S Gubbi, K Araque, Z Abdul Sater, SH Tella, A Demidowich, C Cochran, ...
Journal of the Endocrine Society 3 (Supplement_1), SUN-553, 2019
2019
SUN-331 Clinical Characteristics and Genotype-Phenotype Analysis of MEN1 Patients with Thymic Neuroendocrine Tumors
A Mandl, J Welch, V Parekh, G Veeraraghavan, J Del Rivero, ...
Journal of the Endocrine Society 3 (Supplement_1), SUN-331, 2019
2019
OR29-6 Brown Adipose Tissue Activation in SDHx-Related Pheochromocytoma and Paraganglioma: An Ominous Sign?
Z Abdul Sater, A Jha, A Hamimi, A Mandl, I Hartley, S Gubbi, M Gonzales, ...
Journal of the Endocrine Society 3 (Supplement_1), OR29-6, 2019
2019
The system can't perform the operation now. Try again later.
Articles 1–18